Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
ESMO: iTeos-GSK's TIGIT star shows meaningful improvement
iTeos and GSK are launching their spaceship into another galaxy, touting phase 2 findings that prompted the late-stage GALAXIES Lung-301 trial.
Gabrielle Masson
Sep 14, 2024 2:30am
GSK's mRNA flu vaccine finally bests tricky B strains in phase 2
Sep 12, 2024 4:52am
GSK surrenders HSV vaccine hopes after phase 2 fail
Sep 11, 2024 4:21am
GSK's long-acting asthma drug halved attacks in phase 3
Sep 9, 2024 9:30am
Ex-GSK CEO takes up board post at aging, obesity biotech BioAge
Aug 22, 2024 10:09am
GSK drops ph. 2 HPV vaccine over lack of best-in-class potential
Jul 31, 2024 8:06am